Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M204,655Revenue (TTM) $M52,286Net Margin (%)13.4Altman Z-Score2.3
Enterprise Value $M228,216EPS (TTM) $1.1Operating Margin %24.9Piotroski F-Score5
P/E(ttm)29.9Beneish M-Score-2.6Pre-tax Margin (%)15.9Higher ROA y-yN
Price/Book3.310-y EBITDA Growth Rate %2.6Quick Ratio1.1Cash flow > EarningsY
Price/Sales4.05-y EBITDA Growth Rate %1.2Current Ratio1.4Lower Leverage y-yN
Price/Free Cash Flow15.9y-y EBITDA Growth Rate %-16.6ROA % (ttm)4.2Higher Current Ratio y-yN
Dividend Yield %3.5PEG25.3ROE % (ttm)10.8Less Shares Outstanding y-yY
Payout Ratio %103Shares Outstanding M6,066ROIC % (ttm)12.4Gross Margin Increase y-yN

Gurus Latest Trades with PFE

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactup Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PFEFirst Eagle Investment 2016-03-31 Add$28.56 - $32.28
($30.14)
$ 33.7412%Add 3.98%141,061
PFEBarrow, Hanley, Mewhinney & Strauss 2016-03-31 Reduce-0.01%$28.56 - $32.28
($30.14)
$ 33.7412%Reduce -0.26%53,724,766
PFEDavid Dreman 2016-03-31 Buy 0.02%$28.56 - $32.28
($30.14)
$ 33.7412%New holding5,820
PFEKeeley Asset Management Corp 2016-03-31 Add0.03%$28.56 - $32.28
($30.14)
$ 33.7412%Add 34.41%104,500
PFET Rowe Price Equity Income Fund 2016-03-31 Add0.03%$28.56 - $32.28
($30.14)
$ 33.7412%Add 1.42%14,730,900
PFEDodge & Cox 2016-03-31 Reduce-0.04%$28.56 - $32.28
($30.14)
$ 33.7412%Reduce -58.56%929,604
PFEKen Fisher 2016-03-31 Reduce-0.04%$28.56 - $32.28
($30.14)
$ 33.7412%Reduce -1.82%31,746,148
PFEMario Gabelli 2016-03-31 Reduce-0.04%$28.56 - $32.28
($30.14)
$ 33.7412%Reduce -24.04%537,011
PFECharles Brandes 2016-03-31 Reduce-0.05%$28.56 - $32.28
($30.14)
$ 33.7412%Reduce -1.83%5,536,325
PFEDavid Tepper 2016-03-31 Add0.05%$28.56 - $32.28
($30.14)
$ 33.7412%Add 4.15%2,512,250
PFEVanguard Health Care Fund 2016-03-31 Reduce-0.1%$28.56 - $32.28
($30.14)
$ 33.7412%Reduce -18.09%7,267,526
PFEJohn Paulson 2016-03-31 Add0.17%$28.56 - $32.28
($30.14)
$ 33.7412%Add 117.81%1,378,100
PFENWQ Managers 2016-03-31 Add0.25%$28.56 - $32.28
($30.14)
$ 33.7412%Add 28.00%2,518,601
PFEJoel Greenblatt 2016-03-31 Buy 0.52%$28.56 - $32.28
($30.14)
$ 33.7412%New holding1,577,263
PFEKahn Brothers 2016-03-31 Reduce-0.73%$28.56 - $32.28
($30.14)
$ 33.7412%Reduce -8.11%1,442,543
PFELeon Cooperman 2016-03-31 Sold Out -0.91%$28.56 - $32.28
($30.14)
$ 33.7412%Sold Out0
PFERichard Pzena 2015-12-31 Add$31.33 - $35.45
($33.17)
$ 33.742%Add 0.08%2,161,593
PFEMario Gabelli 2015-12-31 Reduce$31.33 - $35.45
($33.17)
$ 33.742%Reduce -3.16%706,956
PFERuane Cunniff 2015-12-31 Add$31.33 - $35.45
($33.17)
$ 33.742%Add 31.39%14,850
PFEBarrow, Hanley, Mewhinney & Strauss 2015-12-31 Reduce-0.02%$31.33 - $35.45
($33.17)
$ 33.742%Reduce -0.76%53,862,996
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PFE is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
DAMELIO FRANK AExecutive Vice President 2016-05-26Sell100,000$34.49-0.67view
CANGIALOSI LORETTA VSr. Vice President, Controller 2016-05-24Sell86,000$33.970.85view
OLSON LAURIE JExecutive Vice President 2016-05-11Sell4,700$33.52.27view
YOUNG JOHN DGroup President 2016-05-10Sell41,700$33.532.18view
DAMELIO FRANK AExecutive Vice President 2016-05-10Sell192,000$33.661.78view
READ IAN CChairman & CEO 2016-05-09Sell275,000$33.81.36view
SUSMAN SALLYExecutive Vice President 2016-05-09Sell67,884$33.711.63view
HILL CHARLES HExecutive Vice President 2016-05-09Sell29,600$33.841.24view
MADDALUNA ANTHONY JExecutive Vice President 2016-05-09Sell8,950$33.751.51view
SUSMAN SALLYExecutive Vice President 2016-05-05Sell76,116$33.751.51view

Quarterly/Annual Reports about PFE:

    News about PFE:

    Articles On GuruFocus.com
    John Paulson Trims Synergy Sep 23 2016 
    Sanofi Sues Merck Over Patent Infringement Sep 20 2016 
    Pfizer: Hospira Is Future; Xtandi Is Today’s Meal Sep 19 2016 
    Insight from Ray Dalio and Tim Geithner on the Credit Market Sep 13 2016 
    Volatile September Likely After August Losses Sep 06 2016 
    What Makes Apple Undervalued? Sep 02 2016 
    Merck Will Hold Steady on Div Increase Despite Flat Revenue Growth Aug 31 2016 
    Gilead Was Smart to Let Medivation Slip Through its Fingers Aug 29 2016 
    Sanofi's Risk Increases on Acquisition Miss Aug 28 2016 
    Can Novartis Tide Over the Alcon Crisis? Aug 26 2016 

    More From Other Websites
    Pfizer decides against splitting into two companies Sep 26 2016
    6:46 am Pfizer announces they will not pursue splitting Pfizer Innovative Health & Pfizer Essential... Sep 26 2016
    Pfizer Decides Remaining One Company Best Positions Company To Maximize Future Value Creation Sep 26 2016
    “Don’t fire until you see the whites of their eyes” Sep 25 2016
    Axovant Confidence 'Not Swayed' After Rival Alzheimer's Drug Fails Sep 23 2016
    Dow 30 Stock Roundup: Microsoft Rewards Shareholders; GE Wins $1.9B Nuclear Power Contract Sep 23 2016
    Novartis (NVS) Zykadia Positive in Phase III ASCEND-4 Study Sep 23 2016
    [video]Takeover Chatter Around Clovis May Be Overdone Sep 23 2016
    Pfizer Announces Expiration of HSR Waiting Period For Proposed Acquisition of Medivation Sep 23 2016
    Pfizer Announces Expiration of HSR Waiting Period For Proposed Acquisition of Medivation Sep 23 2016
    Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to Buy Abbott's AMO Sep 23 2016
    UPDATE 1-Novartis's Zykadia gets positive results, faces Roche pressure Sep 23 2016
    Lundbeck says Alzheimer's late-stage study fails Sep 22 2016
    Pfizer Invites Public To View And Listen To Webcast Of November 1 Conference Call With Analysts Sep 22 2016
    Pfizer Declares 30-Cent Fourth-Quarter 2016 Dividend Sep 22 2016
    Pfizer Declares 30-Cent Fourth-Quarter 2016 Dividend Sep 22 2016
    'Blockbuster Franchises' Spark M&A Fever For Sarepta, Ariad, Biotechs Sep 21 2016
    Pfizer Invites Public To View And Listen To Webcast Of November 1 Conference Call With Analysts Sep 20 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)